CHEMCRUX ENTERPRISES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 232.9 INR | -1.29% |
|
-4.92% | -24.24% |
| Sales 2022 | 953M 11.47M 15.68M | Sales 2023 | 952M 11.46M 15.66M | Capitalization | 4.4B 52.97M 72.38M |
|---|---|---|---|---|---|
| Net income 2022 | 149M 1.79M 2.45M | Net income 2023 | 144M 1.73M 2.37M | EV / Sales 2022 | 2.27 x |
| Net cash position 2022 | 101M 1.21M 1.65M | Net cash position 2023 | 72.8M 877K 1.2M | EV / Sales 2023 | 4.55 x |
| P/E ratio 2022 |
15.2
x | P/E ratio 2023 |
30.6
x | Employees | 94 |
| Yield 2022 |
1.31% | Yield 2023 |
0.67% | Free-Float | 24.11% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.29% | ||
| 1 week | -4.92% | ||
| Current month | -12.46% | ||
| 1 month | -14.28% | ||
| 3 months | -26.84% | ||
| 6 months | -17.19% | ||
| Current year | -24.24% |
1 week
230.95
247.75
1 month
230.95275.00
Current year
230.95326.00
1 year
230.95359.00
3 years
85.35501.10
5 years
20.00501.10
10 years
7.20501.10
| Managers | Title | Age | Since |
|---|---|---|---|
| Founder | 67 | 82-12-31 | |
Ramesh Kambariya
DFI | Director of Finance/CFO | - | 12-07 |
| Compliance Officer | 28 | 21-03-04 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 21-12-21 | |
| Founder | 67 | 82-12-31 | |
| Founder | 67 | 82-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-24 | 232.9 | -1.29% | 20,412 |
| 24-05-23 | 236 | -1.23% | 13,678 |
| 24-05-22 | 238.9 | -1.42% | 18,199 |
| 24-05-21 | 242.4 | -1.06% | 14,686 |
| 24-05-18 | 245 | -0.35% | 5,783 |
Delayed Quote Bombay S.E., May 24, 2024 at 06:00 am
More quotes
Chemcrux Enterprises Limited is an India-based company. The Company is engaged in manufacturing intermediates for bulk drugs, dyes and pigment industries. It is engaged in manufacturing or processing of bulk drug intermediates like Para Chloro Benzoic, Ortho Benzoic Acid, and Lasamide, among others. The Company's products include 2 Chloro Benzoic Acid, 3 Chloro Benzoic Acid, 4 Chloro Benzoic Acid, 2,4 Dichloro Benzoic Acid, 4 Chloro 3 Nitro Benzoic Acid; 2 Chloro 5 Nitro Benzoic Acid; Meta Nitro Benzoic Acid; Lasamide, and Meta Chloro Per Benzoic Acid. It is engaged in development and execution of various processes, such as High-Pressure Oxidation, Nitration, Amidation, BPEA Sulfonamide and Chlorosulfonation. The Companyâs manufacturing facility is located in Bharuch, Gujarat, India.
Sector
Pharmaceuticals
Calendar
2024-08-08
- Q1 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -24.24% | 41.52M | |
| +38.51% | 727B | |
| +33.05% | 599B | |
| -6.23% | 354B | |
| +18.78% | 328B | |
| +1.35% | 277B | |
| +16.00% | 243B | |
| +8.09% | 205B | |
| -5.77% | 203B | |
| +6.19% | 164B |
- Stock Market
- Equities
- CHEMCRUX6 Stock
